Results 181 to 190 of about 11,649,511 (362)

Factors associated with 30-day drug-related emergency department re-attendance among methamphetamine users: a territory-wide retrospective study in Hong Kong. [PDF]

BMC Emerg Med
Lam RPK, Chan CK, Tse ML, Lau EHY, Tsui MSH, Chan SKW, Rainer TH.   +6 more
europepmc   +1 more source

Lichen Planus-Like Drug Eruption Due to Para-Amino Salicylic Acid

, 1953
Harry Shatin, Orlando Cañizares, Edward L. Worthington   +2 more
openalex   +1 more source

The Influence of the Electric Current on the Absorption of Drugs [PDF]

, 1921
O. Inchley
openalex   +1 more source

A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

Pharmaceutical Research, 1995
G. Amidon, H. Lennernäs, V. Shah, J. Crison   +3 more
semanticscholar   +1 more source

Olaparib synergy screen reveals Exemestane induces replication stress in triple‐negative breast cancer

Molecular Oncology, EarlyView.
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh, Liping Su, Suet Lin Chia, Xiaohe Tian, Haslina Ahmad, Martin R. Gill   +5 more
wiley   +1 more source

A computational workflow for assessing drug effects on temporal signaling dynamics reveals robustness in stimulus-specific NFκB signaling. [PDF]

PLoS Comput Biol
Bozich ER, Guo X, Wilson JL, Hoffmann A.
europepmc   +1 more source

RKIP overexpression reduces lung adenocarcinoma aggressiveness and sensitizes cells to EGFR‐targeted therapies

Molecular Oncology, EarlyView.
RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha, Joana Pinheiro, Rui F. Marques, Patrícia Fontão, Diana Cardoso‐Carneiro, Adriana Mendes, Izabela N. F. Gomes, Ana Carolina Laus, Renato J. da Silva‐Oliveira, Rui Manuel Reis, Olga Martinho   +10 more
wiley   +1 more source

Improving computational drug repositioning through multi-source disease similarity networks. [PDF]

Sci Rep
Le DH.
europepmc   +1 more source

Origin and history of all the pharmacopeial vegetable drugs, chemicals and preparations with bibliography... Prepared under the auspices of and pub. by the American drug manufacturers' association, Washington, D.C

, 1921
John Uri Lloyd
openalex   +2 more sources

EXAMINATION OF NEOARSPHENAMINE. II. THE CONSTITUTION OF THE FRENCH DRUGS [PDF]

, 1922
A. Douglas Macallum
openalex   +1 more source